Status:
COMPLETED
Prediction of pCR by Preoperative Biopsy in Breast Cancer With cCR After Neoadjuvant Chemotherapy.
Lead Sponsor:
Seoul National University Hospital
Conditions:
Breast Neoplasm
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the ability of preoperative biopsy to predict correctly pathologic complete response in breast cancer patients with complete clinical response after neoadjuvan...
Detailed Description
Breast cancer patients who received neoadjuvant chemotherapy and is predicted to have achieved pathologic complete response (pCR) on MRI will enrolled. The enrolled patients will undergo either US-gui...
Eligibility Criteria
Inclusion
- Patients
- with unilateral primary cancer pathologically confirmed before neoadjuvant chemotherapy (NAC)
- who received NAC
- with detectable lesion / clip marker on ultrasound
- with cT1-T3 tumors
- clinical and imaging complete or near-complete response on MRI
- with informed consent
Exclusion
- Multifocal cancer
- Residual microcalcification
- Contralateral breast cancer
Key Trial Info
Start Date :
September 8 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03273426
Start Date
September 8 2016
End Date
February 1 2018
Last Update
April 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080